3963 related articles for article (PubMed ID: 6710291)
1. Management of cutaneous melanoma in the United States.
Balch CM; Karakousis C; Mettlin C; Natarajan N; Donegan WL; Smart CR; Murphy GP
Surg Gynecol Obstet; 1984 Apr; 158(4):311-8. PubMed ID: 6710291
[TBL] [Abstract][Full Text] [Related]
2. Sentinel lymph node biopsy for the T1 (thin) melanoma: is it necessary?
Nahabedian MY; Tufaro AP; Manson PN
Ann Plast Surg; 2003 Jun; 50(6):601-6. PubMed ID: 12783009
[TBL] [Abstract][Full Text] [Related]
3. Malignant melanoma: current management.
Hiyama DT
Ohio Med; 1990 May; 86(5):360-5. PubMed ID: 2338975
[TBL] [Abstract][Full Text] [Related]
4. [Survival analysis in patients with cutaneous malignant melanoma].
Radović-Kovacević V; Pekmezović T; Adanja B; Jarebinski M; Marinković J; Tomin R
Srp Arh Celok Lek; 1997; 125(5-6):132-7. PubMed ID: 9265233
[TBL] [Abstract][Full Text] [Related]
5. Management of malignant melanoma.
Kroon BB; Nieweg OE
Ann Chir Gynaecol; 2000; 89(3):242-50. PubMed ID: 11079795
[TBL] [Abstract][Full Text] [Related]
6. Evidence and interdisciplinary consense-based German guidelines: diagnosis and surveillance of melanoma.
Garbe C; Hauschild A; Volkenandt M; Schadendorf D; Stolz W; Reinhold U; Kortmann RD; Kettelhack C; Frerich B; Keilholz U; Dummer R; Sebastian G; Tilgen W; Schuler G; Mackensen A; Kaufmann R
Melanoma Res; 2007 Dec; 17(6):393-9. PubMed ID: 17992123
[TBL] [Abstract][Full Text] [Related]
7. A clinicopathologic study of prognostic factors in cutaneous malignant melanoma.
Elias EG; Didolkar MS; Goel IP; Formeister JF; Valenzuela LA; Pickren JL; Moore RH
Surg Gynecol Obstet; 1977 Mar; 144(3):327-34. PubMed ID: 841450
[TBL] [Abstract][Full Text] [Related]
8. Melanoma in children and the use of sentinel lymph node biopsy.
Bütter A; Hui T; Chapdelaine J; Beaunoyer M; Flageole H; Bouchard S
J Pediatr Surg; 2005 May; 40(5):797-800. PubMed ID: 15937817
[TBL] [Abstract][Full Text] [Related]
9. The survival benefit to patients with positive sentinel node melanoma after completion lymph node dissection may be limited to the subgroup with a primary lesion Breslow thickness greater than 1.0 and less than or equal to 4 mm (pT2-pT3).
Nowecki ZI; Rutkowski P; Michej W
Ann Surg Oncol; 2008 Aug; 15(8):2223-34. PubMed ID: 18506535
[TBL] [Abstract][Full Text] [Related]
10. Malignant melanoma in Turkey: a single institution's experience on 475 cases.
Tas F; Kurul S; Camlica H; Topuz E
Jpn J Clin Oncol; 2006 Dec; 36(12):794-9. PubMed ID: 17060409
[TBL] [Abstract][Full Text] [Related]
11. The treatment of malignant melanoma of the skin.
Goldman LI
Surg Gynecol Obstet; 1978 May; 146(5):779-82. PubMed ID: 347607
[TBL] [Abstract][Full Text] [Related]
12. Juvenile malignant melanoma.
Reintgen DS; Vollmer R; Seigler HF
Surg Gynecol Obstet; 1989 Mar; 168(3):249-53. PubMed ID: 2919354
[TBL] [Abstract][Full Text] [Related]
13. Multivariable analysis comparing outcome after sentinel node biopsy or therapeutic lymph node dissection in patients with melanoma.
van Akkooi AC; Bouwhuis MG; de Wilt JH; Kliffen M; Schmitz PI; Eggermont AM
Br J Surg; 2007 Oct; 94(10):1293-9. PubMed ID: 17702089
[TBL] [Abstract][Full Text] [Related]
14. Combined inguinal and pelvic lymph node dissection for stage III melanoma.
Hughes TM; Thomas JM
Br J Surg; 1999 Dec; 86(12):1493-8. PubMed ID: 10594495
[TBL] [Abstract][Full Text] [Related]
15. [Sentinel lymph node dissection in patients with malignant melanoma. Diagnostic and therapeutic standards].
Arens A; Osinga J; Schwipper V; Schober O; Tilkorn H; Liebau J
Chirurg; 2003 Jul; 74(7):665-70. PubMed ID: 12883795
[TBL] [Abstract][Full Text] [Related]
16. Malignant melanoma in the lower extremity. A comprehensive overview.
Hutchinson BL
Clin Podiatr Med Surg; 1986 Jul; 3(3):533-50. PubMed ID: 2943398
[TBL] [Abstract][Full Text] [Related]
17. [Important prognostic significance of a sentinel-node biopsy in patients with malignant melanoma].
Keijzer R; Bril H; van der Loo EM; de Graaf PW
Ned Tijdschr Geneeskd; 2004 May; 148(18):884-8. PubMed ID: 15152391
[TBL] [Abstract][Full Text] [Related]
18. The tumor biology of melanoma nodal metastases.
Miliotes G; Albertini J; Berman C; Heller R; Messina J; Glass F; Cruse W; Rapaport D; Puleo C; Fenske N; Petsoglou C; Deconti R; Lyman G; Reintgen D
Am Surg; 1996 Jan; 62(1):81-8. PubMed ID: 8540654
[TBL] [Abstract][Full Text] [Related]
19. [Risk factors for lymph node metastasis in malignant melanoma].
Mussack T; Waldner H; Kharraz-Tavakol A
Zentralbl Chir; 1996; 121(6):465-8. PubMed ID: 8767332
[TBL] [Abstract][Full Text] [Related]
20. [Sentinel node biopsy in cutaneous malignant melanoma of the lower extremities].
Kjaer BK; Knudsen MA; Dahlstrøm KK
Ugeskr Laeger; 1999 Apr; 161(16):2358-61. PubMed ID: 10235040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]